100 related articles for article (PubMed ID: 3723402)
1. Acceleration of the elimination of tenoxicam by cholestyramine in the dog.
Guentert TW; Schmitt M; Defoin R
J Pharmacol Exp Ther; 1986 Jul; 238(1):295-301. PubMed ID: 3723402
[TBL] [Abstract][Full Text] [Related]
2. The influence of cholestyramine on the elimination of tenoxicam and piroxicam.
Guentert TW; Defoin R; Mosberg H
Eur J Clin Pharmacol; 1988; 34(3):283-9. PubMed ID: 3260866
[TBL] [Abstract][Full Text] [Related]
3. The effect of cholestyramine on the pharmacokinetics of meloxicam, a new non-steroidal anti-inflammatory drug (NSAID), in man.
Busch U; Heinzel G; Narjes H
Eur J Clin Pharmacol; 1995; 48(3-4):269-72. PubMed ID: 7589053
[TBL] [Abstract][Full Text] [Related]
4. Enhanced elimination of piroxicam by administration of activated charcoal or cholestyramine.
Ferry DG; Gazeley LR; Busby WJ; Beasley DM; Edwards IR; Campbell AJ
Eur J Clin Pharmacol; 1990; 39(6):599-601. PubMed ID: 2095346
[TBL] [Abstract][Full Text] [Related]
5. Indirect assessment of the enterohepatic recirculation of piroxicam and tenoxicam.
Benveniste C; Striberni R; Dayer P
Eur J Clin Pharmacol; 1990; 38(6):547-9. PubMed ID: 2373127
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal dialysis of digoxin using cholestyramine.
Rawashdeh NM; al-Hadidi HF; Irshaid YM; Battah AK
Pharmacol Toxicol; 1993; 72(4-5):245-8. PubMed ID: 8372041
[TBL] [Abstract][Full Text] [Related]
7. The effect of activated charcoal on the bioavailability of piroxicam in man.
Laufen H; Leitold M
Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):48-52. PubMed ID: 3957490
[TBL] [Abstract][Full Text] [Related]
8. The effect of colestipol and cholestyramine on the systemic clearance of intravenous ibuprofen in rabbits.
el-Sayed YM; al-Meshal MA; al-Angary AA; Lutfi KM; Gouda MW
J Pharm Pharmacol; 1994 Jan; 46(1):73-5. PubMed ID: 8201531
[TBL] [Abstract][Full Text] [Related]
9. Cholestyramine as an adsorbent in acute lindane poisoning: a murine model.
Kassner JT; Maher TJ; Hull KM; Woolf AD
Ann Emerg Med; 1993 Sep; 22(9):1392-7. PubMed ID: 7689801
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of tenoxicam in healthy human volunteers.
Heintz RC; Guentert TW; Enrico JF; Dubach UC; Brandt R; Jeunet FS
Eur J Rheumatol Inflamm; 1984; 7(2):33-44. PubMed ID: 6336292
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of tenoxicam in patients with impaired renal function.
Horber FF; Guentert TW; Weidekamm E; Heizmann P; Descoeudres C; Frey FJ
Eur J Clin Pharmacol; 1986; 29(6):697-701. PubMed ID: 3709612
[TBL] [Abstract][Full Text] [Related]
12. Effect of oral cholestyramine on the elimination of high-dose methotrexate.
Erttmann R; Landbeck G
J Cancer Res Clin Oncol; 1985; 110(1):48-50. PubMed ID: 4019569
[TBL] [Abstract][Full Text] [Related]
13. Enhanced elimination of warfarin during treatment with cholestyramine.
Jähnchen E; Meinertz T; Gilfrich HJ; Kersting F; Groth U
Br J Clin Pharmacol; 1978 May; 5(5):437-40. PubMed ID: 656283
[TBL] [Abstract][Full Text] [Related]
14. Lack of effect of tenoxicam on glibornuride kinetics and response.
Stoeckel K; Trueb V; Dubach UC; Heintz RC; Ascalone V; Forgo I; Hennes U
Br J Clin Pharmacol; 1985 Feb; 19(2):249-54. PubMed ID: 3157397
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of tenoxicam after oral administration in healthy human subjects of various single doses.
Francis RJ; Allen JG; Looi D; Dixon JS; Bird HA; Wright V
Eur J Drug Metab Pharmacokinet; 1987; 12(1):59-63. PubMed ID: 3497039
[TBL] [Abstract][Full Text] [Related]
16. The effect of cholestyramine and activated charcoal on glipizide absorption.
Kivistö KT; Neuvonen PJ
Br J Clin Pharmacol; 1990 Nov; 30(5):733-6. PubMed ID: 2271372
[TBL] [Abstract][Full Text] [Related]
17. Adsorption of methotrexate and calcium leucovorin onto cholestyramine in vitro.
Merino-Sanjuán M; Carrera A; Monte E; Jiménez-Torres NV
Int J Pharm; 2004 Jul; 278(2):283-91. PubMed ID: 15196633
[TBL] [Abstract][Full Text] [Related]
18. Cholestyramine and spironolactone and their combination in digitoxin elimination.
Carruthers SG; Dujovne CA
Clin Pharmacol Ther; 1980 Feb; 27(2):184-7. PubMed ID: 7353337
[TBL] [Abstract][Full Text] [Related]
19. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
Bird HA; Allen JG; Dixon JS; Wright V
Br J Rheumatol; 1985 Nov; 24(4):351-6. PubMed ID: 3877538
[TBL] [Abstract][Full Text] [Related]
20. Reduction of absorption of paracetamol by activated charcoal and cholestyramine: a possible therapeutic measure.
Dordoni B; Willson RA; Thompson RP; Williams R
Br Med J; 1973 Jul; 3(5871):86-7. PubMed ID: 4717848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
